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Disruption of the Podosome Adaptor Protein TKS4
(SH3PXD2B) Causes the Skeletal Dysplasia, Eye, and
Cardiac Abnormalities of Frank-Ter Haar Syndrome
Zafar Iqbal,1,13 Pilar Cejudo-Martin,3,13 Arjan de Brouwer,1 Bert van der Zwaag,4 Pilar Ruiz-Lozano,3
M. Cecilia Scimia,3 James D. Lindsey,5 Robert Weinreb,5 Beate Albrecht,6 Andre Megarbane,7
Yasemin Alanay,8 Ziva Ben-Neriah,9 Mariangela Amenduni,10 Rosangela Artuso,10 Joris A. Veltman,1
Ellen van Beusekom,1 Astrid Oudakker,1,2 Jose´ Luis Milla´n,3 Raoul Hennekam,11,12 Ben Hamel,1
Sara A. Courtneidge,3,* and Hans van Bokhoven1,2
Frank-Ter Haar syndrome (FTHS), also known as Ter Haar syndrome, is an autosomal-recessive disorder characterized by skeletal, cardio-
vascular, and eye abnormalities, such as increased intraocular pressure, prominent eyes, and hypertelorism. We have conducted
homozygosity mapping on patients representing 12 FTHS families. A locus on chromosome 5q35.1 was identiﬁed for which patients
from nine families shared homozygosity. For one family, a homozygous deletion mapped exactly to the smallest region of overlapping
homozygosity, which contains a single gene, SH3PXD2B. This gene encodes the TKS4 protein, a phox homology (PX) and Src homology
3 (SH3) domain-containing adaptor protein and Src substrate. This protein was recently shown to be involved in the formation of actin-
rich membrane protrusions called podosomes or invadopodia, which coordinate pericellular proteolysis with cell migration. Mice lack-
ing Tks4 also showed pronounced skeletal, eye, and cardiac abnormalities and phenocopied the majority of the defects associated with
FTHS. These ﬁndings establish a role for TKS4 in FTHS and embryonic development. Mutation analysis revealed ﬁve different homozy-
gous mutations in SH3PXD2B in seven FTHS families. No SH3PXD2Bmutations were detected in six other FTHS families, demonstrating
the genetic heterogeneity of this condition. Interestingly however, dermal ﬁbroblasts from one of the individuals without an SH3PXD2B
mutation nevertheless expressed lower levels of the TKS4 protein, suggesting a common mechanism underlying disease causation.In 1973, Frank et al. described a patientwithmegalocornea,
brachycephaly, large anterior fontanels, hypertelorism,
anteverted nostrils, thoracolumbar kyphosis, prominent
coccyx, short hands, ﬂexion deformity of ﬁngers, club
feet, and heart murmur and suggested this to be a hitherto
undescribed entity (Figure 1).1 Later, terHaar et al. described
severalmembers of a single family with similar features (see
Figure S1 available online).2 This syndrome is now referred
to as Frank-Ter Haar syndrome (FTHS [MIM 249420]).
A small number of additional FTHS families have been
reported, most within families with consanguineous
unions, suggestive of a recessive inheritance pattern.3–8
FTHS patients usually die in infancy or in early childhood
because of the cardiovascular anomalies, respiratory infec-
tions, or unknown causes. To date, the molecular cause of
FTHS has not been established.
Here we performed homozygosity mapping to localize
the genetic defect in 16 patients from 12 apparently
unrelated FTHS families with known or suspected consan-
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studies revealed a common ancestor for the parents of
some of the patients eight to ten generations back
(Figure S1). Written informed consent was obtained for
all patients, and research was approved by the local ethics
committee of the Radboud University Nijmegen Medical
Centre. Genome-wide homozygosity mapping was carried
out with the Affymetrix mapping 250K SNP array, on DNA
fragments in the 200 to 1100 bp size range ampliﬁed
from 250 ng genomic DNA. The data were analyzed by
genotyping console. The mapping revealed a region on
chromosome 5q35.1 for which 12 out of 16 patients had
overlapping regions of homozygosity (Figure 1). To
conﬁrm the homozygosity, we used microsatellite markers
on chromosome 5q35.1 region. Families 1 and 2, both of
Dutch origin, shared the same haplotype, suggesting a
founder effect. The common region of homozygosity
spanned only 0.27 Mb and comprised the NEURL1B gene
and part of the SH3PXD2B gene. Interestingly, analysis of
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number analyzer for GeneChip (CNAG)9 revealed a homo-
zygous deletion in the patients of family 7, who mani-
fested the typical FTHS phenotype (Table 1).5 Genomic
quantitative PCR analysis conﬁrmed the homozygous
deletion and mapped the endpoints between STK10
(MIM 603919) and AK026748 (Figure S1). This deletion
harbors the UBTD2 (MIM 610174) and SH3PXD2B genes.
Thus, the cumulative results of homozygosity mapping
and copy number analysis identiﬁed SH3PXD2B as the
most plausible FTHS candidate gene (Figure 1).
Next, we screened the SH3PXD2B gene in probands rep-
resenting 13 FTHS families from our cohort by direct DNA
sequencing. Intron-speciﬁc primers were designed for the
ampliﬁcation of exons 1–13 of the SH3PXD2B gene (Table
S1; data not shown). The segregation of DNA variants was
veriﬁed in the corresponding families. In addition, we
analyzed all variants in 50 unrelated control individuals
to exclude benign polymorphisms. A total of four addi-
tional homozygous mutations were identiﬁed in six fami-
lies (Figure 1). In families 1 and 2, a homozygous insertion
c.147insT was detected, which predicted the creation of an
immediate stop in the same codon (p.F49X), in all three
affected individuals available for testing. In families
6 and 9, which are of unrelated ethnicity, we detected
a homozygous 1 bp deletion c.969delG, which predicts
a frameshift followed by a premature stop codon
(p.G323fsX19; Figure 1; Figure S1). In family 12, we identi-
ﬁed a substitution c.129C>T (p.R43W), which disrupts a
highly conserved amino acid within the phox homology
(PX) domain of the protein (Figure 1) and which is
predicted to abolish binding to phosphoinositides.10,11
Finally, a c.76-2A>C splice site mutation was identiﬁed
in an additional patient whowas not included for homozy-
gosity mapping (family 13), which disrupts the strictly
conserved adenosine of the splice acceptor site. All muta-
tions segregated within the respective families in a pattern
compatible with autosomal-recessive inheritance (Fig-
ure S1). None of the truncating mutations were detected
in a minimum of 50 control individuals. In addition,
none of 210 control chromosomes contained the nontrun-
cating mutations. Together, these data establish that
SH3PXD2B gene mutations are causative for a subset
(7 of 13) of FTHS families. The phenotype of patients
with an intragenic SH3PXD2Bmutation does not appear to
be notably different from that of the patients of family 7,
who carry a deletion that also disrupts UBTD2 (Table 1).
Apparently, the function of UBTD2 is at least partially
redundant in humans. The clinical features in FTHS
patients in whom no mutations were detected are highly
similar to those of patients with SH3PXD2B mutations,
indicating genetic heterogeneity in FTHS. Indeed, the result
of homozygosity mapping analysis excludes the 5q35.1
locus in four families and supports the involvement of
multiple other loci.
The protein product of the SH3PXD2B gene is known as
TKS4 (tyrosine kinase substrate with four Src homology 3
[SH3] domains). It is an adaptor protein with a PX domain,The Americafour SH3 domains, and a substrate of the tyrosine kinase
Src.10 In Src-transformed murine ﬁbroblasts, Tks4 is
required for the formation of podosomes/invadopodia,
which are dynamic, actin-rich plasma membrane protru-
sions involved in cell adhesion, migration, and matrix
degradation.12 In these cells, Tks4 recruits to podosomes
the membrane type-1 matrix metalloprotease (MT1-
MMP),10 an obligate podosome/invadopodia protein
involved in pericellular proteolysis of extracellular
matrix.13 A paralog of Tks4, Tks5, encoded by SH3PXD2A
on chromosome 10, is also an adaptor protein involved
in podosome/invadopodia formation,14 but none of the
unexplained FTHS patients showed homozygosity at this
locus (data not shown). Podosomes are necessary for the
adhesion andmigration of a variety of cell types, including
macrophages, dendritic cells, osteoclasts, vascular smooth
muscle, and endothelial cells,12,13,15 several of which may
be relevant to the FTHS phenotype.
The TKS4 protein levels in human primary dermal ﬁbro-
blasts were analyzed by immunoblot of total cell lysates as
previously described.10 A Tks4 signal was observed in
control ﬁbroblasts, whereas no signal could be detected in
cells from patients of families 1 and 2 with an SH3PXD2B
mutation, demonstrating that FTHS can be caused by
homozygous loss-of-function mutation of SH3PXD2B (Fig-
ure 1). Quantitative RT-PCR analysis was conducted to
analyze the SH3PXD2B transcript in these ﬁbroblasts.
Normal levels of SH3PXD2B transcript were detected for
three affected individuals with the c.147insT (F49X) muta-
tion, even though no TKS4 protein was detected. This indi-
cates that the premature stop codon introduced by this
mutation does not result in nonsense-mediated RNA decay
and likely results instead in a truncated unstable protein.
Fibroblasts fromother affected individuals with SH3PXD2B
mutations were not available, precluding a more detailed
analysis.
No SH3PXD2B mutations were identiﬁed in six FTHS
families, including families 3, 4, and 5, for which patients
showed homozygosity at the 5q35.1 locus. It is possible
that mutations in cis-regulatory elements have been
missed in these three families. In keeping with this
hypothesis, although ﬁbroblasts derived from the patient
from family 37 with no mutation in the SH3PXD2B coding
sequence did contain detectable Tks4 protein, its abun-
dance was sharply reduced compared to wild-type cells.
Quantitative PCR did not reveal any differences at the
mRNA level (data not shown), so it is possible that a muta-
tion affecting TKS4 protein synthesis or stability has been
missed. Alternatively, this patient carries a mutation in
another gene which regulates TKS4 protein homeostasis.
Genetic heterogeneity of FTHS would also be consistent
with the observation that there are several other homozy-
gous regions in patients from each of six unsolved families.
The results of homozygosity mapping also support the
involvement of multiple other loci.
Murine Tks4 is 87% identical to the human paralog and
has a similar domain structure. To gain more insight inton Journal of Human Genetics 86, 254–261, February 12, 2010 255
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Figure 1. Clinical Features of FTHS, Homozygosity Mapping, and Analysis of SH3PXD2B
(A) Left: girl from family 1 showing broad face, megalocornea, low nasal bridge, upturned nares, open mouth appearance, full cheeks,
and small chin. Right: the same girl at a later age showing sustained facial features.
(B) Facial feature of patient 9.1 at age 3.5 years demonstrating hypertelorism, large eyes, full cheeks, widemouth, microretrognathia, and
large ears.
(C) Patient 9.2 showing brachycephaly, high forehead, hypertelorism, large eyes, megalocornea, broad mouth, and small chin.
(D) Caudal appendage at coccyx with prominent skin fold (family 6).
(E) Left: hand of patient 9.1 showing short ﬁngers with short and broad terminal phalanges. Camptodactyly was seen only after birth.
Right: X-rays showing generalized osteopenia, short tubular bones of the hand.
(F) Increased lower thoracolumbar kyphosis and brachycephaly in patient 9.1.
(G) Poor modeling of long bones including the distal radius and ulna in patient 1.
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where Tks4 may play a role during development, we per-
formed cRNA in situ hybridization analysis of embryonic
mouse cryosections with probes speciﬁc for Sh3pxd2b.
Spatiotemporally restricted Sh3pxd2b expression was
observed at various embryonic development stages in
tissues that are affected in FTHS patients: heart, bone,
and eye (Figure S2). At embryonic day (E) 10.5, a speckled
expression of Sh3pxd2b was observed in heart and hind-
brain, which appeared to have increased at E12.5, and
involved a subset of cells on the luminal side of the left
ventricular wall in the case of the heart and neuroepithe-
lium in the case of the brain. At E14.5, expression was
present in developing bones (e.g., the proximal ribs, lower
jaw, clavicle), but the expression in the heart was no longer
detectable. At stages E16.5 and E18.5, strong expression
was seen in the long bones of the limbs, particularly in
the growth plates, as well as in the facial and cranial bones
and the primordial incisor. Expression in the ribs was seen
in the proximal regions in those areas where the transition
from cartilage to bone is expected to occur. Disruption of
expression during rib and vertebral bone development
could explain the chest deformities and kyphosis observed
in FTHS. Expression in the eye at E16.5 was highly speciﬁc
for the ganglion cell layer. The signiﬁcance of this observa-
tion for the occurrence of glaucoma in FTHS patients and
in Sh3pxd2bmice (see below) is presently not clear. Overall,
the fact that Sh3pxd2b expression can be found in tissues
that are affected in FTHS suggests that it is required for
the correct patterning and development of these organs.
However, expression is also observed in areas that do not
directly relate to the FTHS phenotype, for example the
hindbrain. In the future it will be interesting to determine
whether this is relevant to the motor retardation
frequently observed in affected individuals (Table 1).
To investigate the function of Tks4 in vivo, we analyzed
Sh3pxd2bmutant mice that were generated via a gene-trap
strategy by Lexicon Pharmaceuticals (embryonic stem cell
clone ID GST_1527_E5). Inactivation of Sh3pxd2b in these
mice is caused by insertion of the gene-trap vector VICTR
48 between exons 3 and 4 of the Sh3pxd2b gene on chro-
mosome 11.Mice were kept in amixed genetic background
(C57BL6/a129SvJ). All animal experiments were approved
by the Burnham Institute’s Institutional Animal Research
Committee. Disruption of the Sh3pxd2b gene was assessed
by PCR of genomic DNA and immunoblot on total lysates(H) Schematic representation of the 5q35.1 region that is homozy
deletion was identiﬁed upon analysis of the 250K SNP array data via t
the deletion is encircled in blue. The overlap between the deletion an
SH3PXD2B (gray). An asterisk indicates patients in whom a mutation
was used for the coordinates in the genetic map.
(I) Schematic representation of TKS4 protein structure with an N-t
mutations is indicated.
(J) Position of the amino acid substitution R43W at a highly conserv
normal function in phosphoinositide binding and membrane associ
(K) Immunoblot analysis with a TKS4-speciﬁc antibody detects a 120
formed with Src (Src-3T3), and in ﬁbroblasts from control individu
different patients from families 1 and 2 with an SH3PXD2B mutati
in cells from another FTHS patient from family 3 without an SH3PX
The Americafrommurine embryonic ﬁbroblasts.10 No Tks4 protein was
detected in ﬁbroblasts derived from E12.5 homozygous
mutant embryos, suggesting that the gene trap caused a
complete loss of gene expression from this locus; therefore,
these mice will be referred to as Sh3pxd2b null. We noted
that Sh3pxd2b null mice were born at Mendelian ratios,
but approximately 20% of the null mice died in the ﬁrst
weeks of life of undetermined causes. For those that
survived, lifespan did not appear to be compromised (Fig-
ure 2). At birth, Sh3pxd2b null mice were on average the
same size as their wild-type and heterozygous littermates.
However, the null mice were markedly smaller by weaning,
and this growth retardation was maintained during their
lives (Figure 2; Figure S3).
Alizarin red staining of Sh3pxd2b null skulls demon-
strated severe craniofacial defects characterized by a shorter
nasal bone, micrognathia, hypertelorism, sagittal suture
agenesis, and the presence of wormian bones (Figure 2;
Figure S4). Mouse skeletons were also analyzed by X-ray
with a FAXITRONMX-20machine. Mutantmice displayed
marked kyphosis, poorly aligned teeth, anomalies in the
iliac crest, and a prominent xiphisternum when compared
to heterozygotes and wild-types (Figure 2). Most of these
developmental abnormalities bear a remarkable similarity
to the skeletal defects of FTHS patients (Table 2).
Many FTHS patients have cardiac deﬁciencies. To inves-
tigate possible heart defects in the Sh3pxd2b null mice, we
dissected, ﬁxed, embedded, and sectioned hearts at 5 mm
for hematoxylin and eosin (H&E) staining. Coronal
sectioning of hearts showed that all Sh3pxd2b null mice
examined had cardiac abnormalities (8 of 8), although
there was variability in the range of phenotypes seen.
Anomalies included dysmorphic ventricular chambers (8
of 8), thin mitral valves (4 of 8) that may be causative of
prolapse, and immature and disarrayed trabeculae (6 of 8)
with frequent apical indentation (5 of 8) (Figure 2). Echo-
cardiographic analyses were also performed in male mice
with aVisual Sonic Vevo 770 ﬁttedwith an 8–15MHz linear
array transducer, as previously described.16,17 This analysis
revealed reduced thickness of the septal anterior wall and
bradycardia (300–400 bpm compared to >500 for wild-
types) (3 of 3) (Figure 2). It is of interest to note that FTHS
individuals also showed septal, ventricular, andmitral valve
defects (Table 2). Further analysis will be required to deter-
mine the molecular basis for these observations.gous in 12 patients and homozygously deleted in family 7. The
he CNAG algorithm, as visualized by the bottom diagram in which
d the smallest region of homozygosity harbors only a single gene,
has been identiﬁed. The hg18 UCSC genome build (version 2006)
erminal PX domain and four SH3 domains. The position of the
ed region within the PX domain predicts a disruptive effect on its
ation.
kDa band in mouse ﬁbroblasts (3T3), in mouse ﬁbroblasts trans-
als (control). No such product is seen in ﬁbroblasts from three
on. The TKS4 band was also present but at clearly reduced levels
D2B mutation (unsolved). Tubulin was used as a loading control.
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Table 1. Clinical Features of FTHS Patients in This Study
Family 1 2 3 4 5 6 7 8 9 10 11 12 13
Patient 1 1 2 1 1 1 1 1 2 1 1 2 1 2 1 1 1
Gender M M M M M F F M F F M M M F F M M
Consanguinity  þ þ þ þ þ þ þ þ þ þ þ þ þ  þ þ
Motor retardation þ þ þ þ þ þ þ þ þ þ  þ þ
Craniofacial Abnormalities
Prominent forehead þ þ þ þ þ þ þ þ þ þ þ þ   þ þ þ
Brachycephaly þ þ þ þ þ þ þ þ þ  þ þ    þ þ
Wide anterior fontanel þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Hypertelorism þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Congenital glaucoma þ þ þ  þ  þ þ a     þ b 
Large cornea þ þ þ þ þ þ þ þ  þ þ þ þ þ þ þ
Prominent eyes þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Full cheeks þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Anteverted nostrils þ þ þ þ  þ þ    þ þ þ þ þ
Broad mouth þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Broad alveolar ridges þ þ  þ þ þ    þ þ þ þ
Micrognathia þ þ þ þ þ þ  þ þ þ þ þ þ þ  þ þ
Protruding ears þ þ þ þ þ    þ þ  þ
Skeletal Abnormalities
Kyphosis þ þ  þ þ þ   þ     þ þ
Prominent coccyx þ þ þ þ þ þ þ þ   þ þ  þ þ
Bowing of long bones þ þ þ  þ  þ þ       þc þ
Short hands þ þ þ  þ þ þ þ  þ þ    þ þ
Flexion deformity
of ﬁngers
þ   þ þ þ þ   þ   þ þ   þ
Club feet þ þ  þ   PA þ þ    þ d þ
Cardiac Manifestations
Mitral valve anomaly þ þ MVP þ       þe 
Double right outlet þ þ      
Ventricular septal defect  þ þ  þ   þ HCM ASD þ þf
Other abnormalities gall stones brain MRIg auricular pits
SH3PXD2B mutation þ þ þ    þ þ þ  þ þ    þ þ
The following abbreviations are used: ASD, atrial septal defect; VSD, ventricular septal defect; MVP, mitral valve prolapsed; PA, pes adductus; HCM, hypertrophic
cardiomyopathy. þ denotes that the feature is present and – denotes that the feature was not detected in the patients. Family 2 was described by ter Haar et al.2
and Hamel et al.,3 family 3 by Wallerstein et al.,7 families 4 and 6 by Maas et al.,4 and family 7 by Megarbane et al.5
a Bilateral iris and retinal coloboma.
b Retinal detachment, sudden vision loss at age 7.
c Severe genu valgum, dislocated left knee, bilateral hips, both elbows.
d Pes valgus.
e Cardiomegaly, severe mitral and aortic valve prolapsed.
f VSD, ASD, and patent ductus arteriosis.
g Slightly prominent ventricles on MRI.Because one of the most highly penetrant features of
the FTHS patients involves the eye, we also looked for
eye phenotypes in the mice. Intraocular pressure (IOP)
was directly measured in both eyes within the ﬁrst 7
min after injecting ketamine and xylazine anesthesia as258 The American Journal of Human Genetics 86, 254–261, Februarypreviously described.18 Data were analyzed via Student’s
t test. This analysis demonstrated that the Sh3pxd2b
null mice had glaucoma, which was not detected in
either wild-type or heterozygous littermates (Figure 2).
Analysis of H&E-stained ﬁxed sections of eyes revealed12, 2010
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Figure 2. Developmental Defects Due to
Sh3pxd2b Inactivation in the Mouse
(A) Mice in which the Sh3pxd2b gene is in-
activated because of a gene-trap insertion
have increased mortality during the ﬁrst
3 weeks of life.
(B) Sh3pxd2b null (/) mice experience
severe growth retardation as compared to
wild-type and heterozygous mutants. The
image shown is of mice at 3 months of age.
(C) Lateral and dorsal view of wild-type
(WT) and Sh3pxd2b/ mouse heads from
10-week-old mice. Sh3pxd2b/ mice have
craniofacial defects characterized by a
shorter distance between nose and fore-
head and hypertelorism. A depressed nasal
bridge and small chin can also be seen.
(D) Alizarin red stained skulls of 5-month-
old WT and Sh3pxd2b/ mice. Mutants
have open sagittal sutures, as well as
wormian bones (*). The following abbrevi-
ations are used: ls, lambdoid suture; ss,
sagittal suture; cs, coronal suture.
(E) Other skeletal defects in Sh3pxd2b/
adult (2-month-old) mice visible by X-ray
imaging include the teeth (reduced size),
neurocranium (decreased anterior-poste-
rior diameter), and viscerocranium (short
maxilla, short mandibula, and more
vertical orientation of skull base).
(F) View of the iliac crest showing short-
ening and widening with decreased ﬂaring
of iliac wings in the null mice at 2 months
of age.
(G) Prominence of the xyphoid part of
the sternum is noted in the null mice at
2 months of age.
(H) The vertebral column, showingmarked
thoracic kyphosis and mild lumbosacral
lordosis in null mice at 2 months of age.
(E–H) Defects indicated by arrowheads
and square.
(I)H&E-stained coronal heart sections from
4-month-old WT and old Sh3pxd2b/
mice. The ventricular septum thickness is
indicated with a black line. The asterisks
indicate apical indentation. Carats mark
the dysmorphic chambers, and the blue
line shows the ventricular wall thickness.
The following abbreviations are used: RV,
right ventricle; LV, left ventricle.
(J) Coronal H&E sections of 4-month-oldWTand Sh3pxd2b/mice show themitral valves, which are indicated by the black arrowheads.
(K) Echocardiogram of 2.5-month-old WT and Sh3pxd2b/ mice. Sh3pxd2b/ mice were bradycardic, as shown by the longer interval
(red line) between two consecutive systoles.
(L) IOP measurements of eyes from WT and Sh3pxd2b/. The ages ranged from 4 to 16 months in both groups.
(M) H&E staining of anterior segments of eyes fromWT and Sh3pxd2b/mice reveal the structure of the cornea and iris. Note that the
angle between the cornea (C) and the iris (Ir) extends back to the ciliary body (CB) in the wild-type eye. In contrast, homozygous null
mice had apposition of the peripheral iris to the corneal endothelium (between arrows). In the homozygous null mice, the cornea bulges
anteriorly. Scale bar represents 300 mm.substantial variability in the structure of Sh3pxd2b null
mouse eyes. Apposition of the peripheral iris to the
corneal endothelium and enlargement of the cornea
was generally noted (Figure 2). The corneal enlargement
was similar to human megalocornea except that in the
mice the cornea was largest in older animals, suggesting
continued enlargement with increasing age. Aqueous
humor drains from the anterior chamber of the mouse
eye via trabecular outﬂow and uveoscleral outﬂow, whichThe Americaboth originate between the iris and cornea adjacent to
the ciliary body.19,20 Hence, the peripheral apposition
of the iris and cornea in the Sh3pxd2b null eyes likely ob-
structed outﬂow and induced elevated intraocular pres-
sure in a manner analogous to closed angle glau-
coma.21,22 Furthermore, corneal thickening, increased
opacity, and phtisis bulbi with partial exudation of the
lens through a central corneal perforation were some-
times noted.n Journal of Human Genetics 86, 254–261, February 12, 2010 259
Table 2. Comparison of Features Present in FTHS Patients and
Sh3pxd2b/ Mice
FTHS Patients Sh3pxd2b/ Mice
Craniofacial
Brachycephaly þ 
Suture agenesis þ þ
Wormian bones þ þ
Prominent forehead þ þ
Hypertelorism þ þ
High palate þ þ
Dentition abnormalities þa þ
Micrognathia þ þ
Skeletal
Prominent sternum/xyphoid  þ
Pectus excavatum þ 
Increased thoracic kyphosis þ þ
Pelvic anomalies þb þ
Bowing of long bones þ 
Extremity abnormalities þc ND
Prominent coccyx þ NA
Eye
Glaucoma þ þ
Megalocornea þ þd
Buphthalmos þ þ
Cardiac
Ventricular defectse þ þ
Other
Growth retardationf þ þ
Adiposity ?g þ
The following abbreviations are used: ND, not determined; NA, not applicable.
þ denotes that the feature is present and – denotes that the feature was not
detected in the patients or mice.
a Patients present broad alveolar ridges.
b Patients present hip dysplasia, whereas mice have malformation of iliac crest.
c Patients present short hands, flexion deformity of hands, and club feet.
d Unlike megalocornea in humans, the enlargement of the cornea increases
with age.
e Defects in patients include mitral valve anomalies, double-outlet right
ventricle, and ventricular septal defects. In the mice, dysmorphia of the septal
anterior wall, ventricles, and mitral valve have been observed.
f Patients have been described to be in the lower weight and height centiles as
they grow.
g One patient reported to have ‘‘little or no subcutaneous fat.’’Taken together, many of the abnormalities we observed
in the Sh3pxd2b nullmice are highly reminiscent of pheno-
types characteristic of FTHS patients, particularly the
skeletal, cardiac, and eye phenotypes, and conﬁrm a role
for the TKS4 protein in the generation of FTHS (Table 2).
Two other striking features of the Sh3pxd2b null mice are
their decreased size and marked loss of adipose tissue
(Figure 2; Figures S3 and S5). Although these features are260 The American Journal of Human Genetics 86, 254–261, Februarynot currently part of a FTHS diagnosis, we note that many
affected individuals are of short stature,2,4,7 and lack of
adiposity has beennoted in at least one case.7 Very recently,
a mutant mouse with skeletal, eye, and adipose abnormali-
ties was shown to express a truncated form of Tks4:23 glau-
coma and cardiac defects were not noted, suggesting that
complete loss of Tks4may give rise to different phenotypes
than truncation of the protein product.
Our results establish a crucial role for Tks4 in bone,
heart, and eye development, as well as a variety of other
tissues. To date, the only known function of Tks4 is in po-
dosome formation,10 leading us to speculate that defective
podosome formation may contribute to a human develop-
mental disorder. FTHS was originally reported as an atyp-
ical form of Melnick-Needles syndrome, which is usually
caused by mutation of the FLNA gene (MIM 300017).24
In osteoclasts, ﬁlamin A is present in the podosome belt,
and its cleavage by calpain is necessary for osteoclast
spreading and motility during bone development and
homeostasis.25 Given the apparent genetic heterogeneity
of FTHS, it is likely that other FTHS cases and related disor-
ders such as megalocornea mental retardation syndrome
(MIM 249310) and serpentine ﬁbula-polycystic kidney
syndrome (MIM 600330) have defects in genes that might
interact with TKS4 and/or in genes involved in podosome
formation or function, which may facilitate the identiﬁca-
tion of causative genes for these conditions.Supplemental Data
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